Members of the George Washington University (GW) Cancer Center, including Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity, recently published several journal articles and patient-focused pieces highlighting the GW Cancer Center’s work in…
Tommy Ballard has been with GW since 2013 and manages the operational and administrative functions for the GW Cancer Center's clinical programs.
What brought you to GW?
The George Washington University (GW) Cancer Center is pleased to announce that Vishal A. Patel MD, FAAD, FACMS, an accomplished Mohs/Dermatologic surgeon and cutaneous oncologist, has joined the GW Cancer Center. He will serve as the director of the recently established Cutaneous Oncology…
Cancer of the skin is by far the most common of all cancers with melanoma being the cause of the majority of skin cancer deaths.
The George Washington University (GW) Cancer Center recently hosted Improving Care for Sexual and Gender Minorities: A Symposium for Health Care Professional Students and Faculty at the Elliott School of International Affairs.
Gazing at the iconic 19th-century Japanese woodcut known as “The Great Wave off Kanagawa," one would hardly suspect it contains a key to a medical breakthrough. Yet the pigment in the artwork has opened a new perspective in the treatment of juvenile cancer.
Innumerable questions and concerns loom after a cancer diagnosis. Among them: Should I participate in a clinical trial, or should I stick with the standard of care? Here's an inside look at the clinical trials process.
As little as two decades ago early adopters of immunotherapy, looking to harness the body’s immune system to fight disease, toiled in the shadow of the holy trinity of cancer therapy - surgery, chemotherapy, and radiation therapy. Now, the immunological approach to cancer treatment has undergone…
In June 2018, before a room full of oncology experts, Robert Siegel, MD ’77, associate center director for education, training, and network development at the GW Cancer Center, described a new treatment developed for patients suffering from oropharyngeal cancer.
The future of cancer research, in the opinion of Katherine Chiappinelli, PhD, of the GW School of Medicine and Health Sciences, revolves around combining immunotherapy with other treatments.